Table 1.
Baseline patient characteristics
| Parameters | HUA (n = 869) | Non-HUA (n = 7982) | Statistic | P-value |
|---|---|---|---|---|
| Age (years) | 60.96 ± 8.31 | 59.84 ± 7.61 | 4.22 | < 0.001 |
| BMI (kg/m2) | 26.88 ± 3.47 | 25.31 ± 3.51 | 12.88 | < 0.001 |
| WC (cm) | 91.3 ± 9.01 | 85.34 ± 9.34 | 18.56 | < 0.001 |
| SBP (mmHg) | 135.76 ± 18.06 | 132.63 ± 18.49 | 4.91 | < 0.001 |
| DBP (mmHg) | 79.41 ± 10.93 | 78.03 ± 10.83 | 3.67 | < 0.001 |
| GGT (U/L) | 27.56 (19.70, 42.33) | 19.90 (15.00, 28.50) | 17.34 | < 0.001 |
| Cr (µmol/L) | 83.29 ± 22.71 | 68.04 ± 14.68 | 28.21 | < 0.001 |
| TC (mmol/L) | 4.75 ± 0.99 | 4.89 ± 0.95 | -4.28 | < 0.001 |
| TG (mmol/L) | 2.00 ± 1.45 | 1.56 ± 1.07 | 11.56 | < 0.001 |
| HDL-C (mmol/L) | 1.29 ± 0.33 | 1.45 ± 0.38 | -12.93 | < 0.001 |
| LDL-C (mmol/L) | 2.98 ± 0.86 | 3.11 ± 0.82 | -4.64 | < 0.001 |
| FPG (mmol/L) | 6.09 ± 1.64 | 5.81 ± 1.69 | 4.78 | < 0.001 |
| FLI | 49.45 (30.51, 71.49) | 27.23 (13.51, 48.35) | 19.84 | < 0.001 |
| Sex (M/F) | 582/287 | 2508/5474 | 460.01 | < 0.001 |
| Smoking, n (%) | 266 (30.6) | 1332 (16.7) | 99.94 | < 0.001 |
| Drinking, n (%) | 423 (48.7) | 2112 (26.5) | 182.22 | < 0.001 |
| HTN, n (%) | 643 (73.4) | 4422 (55.4) | 99.41 | < 0.001 |
| DM, n (%) | 366 (42.1) | 2304 (28.9) | 62.30 | < 0.001 |
| High TG, n (%) | 436 (50.2) | 2566 (32.1) | 108.13 | < 0.001 |
| Low HDL, n (%) | 211 (24.3) | 909 (11.4) | 115.54 | < 0.001 |
| MS, n (%) | 421 (48.5) | 2105 (26.4) | 191.52 | < 0.001 |
| METS-IR | 41.37 ± 7.26 | 37.19 ± 13.28 | 9.47 | < 0.001 |
Data are expressed as mean ± standard deviation for normally distributed variables and as median (interquartile range) for non-normally distributed variables
BMI body mass index, WC waist circumference, SBP systolic blood pressure, DBP diastolic blood pressure, GGT glutamyl transpeptidase, CR creatinine, TC total cholesterol, TG triglyceride, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, FPG fasting plasma glucose, FLI fatty liver index, HTN hypertension, DM diabetes mellitus, MS metabolic syndrome, METS-IR metabolic score for insulin resistance